secwatch / observer
8-K filed November 28, 2025, 6:59 PM ET ticker ABCL CIK 0001703057
other material confidence high sentiment neutral materiality 0.40

AbCellera Biologics Inc. (ABCL): auditor change — AbCellera dismisses KPMG, appoints EY as auditor for FY2026 after tender

AbCellera Biologics Inc.

item 4.01item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

AbCellera Biologics Inc. dismissed KPMG LLP as its auditor.

Action
dismissal
Auditor
KPMG LLP
Exact text from the filing
On November 24, 2025, the Audit Committee of the Board of Directors (the "Audit Committee") of AbCellera Biologics Inc. (the "Company") approved the dismissal of KPMG LLP ("KPMG") as the Company's independent registered public accounting firm, effective following the completion of KPMG's audit of the Company's consolidated financial statements for the fiscal year ending December 31, 2025, and the filing of the Company's Annual Report on Form 10-K for that fiscal year.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

AbCellera Biologics Inc. engaged Ernst & Young LLP as its auditor.

Action
engagement
Auditor
Ernst & Young LLP
Exact text from the filing
on November 24, 2025, the Audit Committee selected Ernst & Young LLP ("EY") as the Company's new independent registered public accounting firm for the fiscal year ending December 31, 2026
View on SEC.gov

Browse all auditor changes →

AbCellera Biologics Inc. filing history →

Source: SEC EDGAR
accession 0001703057-25-000032
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.